Company news
Cipher Pharmaceuticals Inc. news in 2022
Cipher Pharmaceuticals Inc.'s news releases, calls and decks from 2022, newest first.
Cipher Pharmaceuticals Reports Strong Third Quarter Results, Highlighted by USD$1.09 in Cash Per Share
November 10, 2022
Cipher Pharmaceuticals schedules Q3 2022 earnings release and conference call
October 26, 2022
Cipher Pharmaceuticals Strengthens Leadership Team with Appointment of New CFO
August 11, 2022
Cipher Pharmaceuticals Reports Second Quarter 2022 Financial Results
August 11, 2022
Cipher Pharmaceuticals Schedules Q2 2022 Earnings Release and Conference Call
August 5, 2022
Cipher Pharmaceuticals Announces Results of Annual and Special Meeting of Shareholders and Thanks Director Dr. John Mull
June 22, 2022
Cipher Pharmaceuticals Reports Strong First Quarter 2022 Financial Results
May 12, 2022
Cipher Pharmaceuticals Schedules Q1 2022 Earnings Release and Conference Call
May 9, 2022
Cipher Pharmaceuticals Announces Partner, Moberg Pharma's Regulatory Submission to FDA for North American Phase 3 Study
March 22, 2022
Cipher Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results
March 17, 2022
Cipher Pharmaceuticals Schedules Q4 2021 Earnings Release and Conference Call
March 11, 2022
Cipher Pharmaceuticals Announces Extension of Distribution and Supply Agreement with Sun Pharmaceutical Industries Inc.
March 10, 2022